Open Access
Issue
Vet. Res.
Volume 39, Number 3, May-June 2008
Number of page(s) 12
DOI http://dx.doi.org/10.1051/vetres:2008013
Published online 29 February 2008
How to cite this article Vet. Res. (2008) 39:36
References of  Vet. Res. (2008) 39:36
  1. Altet L., Francino O., Solano-Gallego L., Renier C., Sánchez A., Mapping and sequencing of the canine NRAMP1 gene and identification of mutations in leishmaniasis-susceptible dogs, Infect. Immun. (2002) 70:2763-2771 [CrossRef] [PubMed].
  2. Blackwell J., Mohamed H., Ibrahim M., Genetics and visceral leishmaniasis in the Sudan: seeking a link, Trends Parasitol. (2004) 20:268-274 [CrossRef] [PubMed].
  3. Bucheton B., Abel L., Kheir M., Mirgani A., El-Safi S., Chevillard C., Dessein A., Genetic control of visceral leishmaniasis in a Sudanese population: candidate gene testing i ndicates a linkage to the NRAMP1 region, Genes Immun. (2003) 4:104-109 [CrossRef] [PubMed].
  4. Burgner D., Jamieson S., Blackwell J., Genetic susceptibility to infectious diseases: big is beautiful, but will bigger be even better? Lancet Infect. Dis. (2006) 6:653-663.
  5. Cartegni L., Chew S., Krainer A., Listening to silence and understanding nonsense: exonic mutations that affect splicing, Nat. Rev. Genet. (2002) 3:285-298 [CrossRef] [PubMed].
  6. Cartegni L., Wang J., Zhu Z., Zhang M., Krainer A., ESEfinder: a web resource to identify exonic splicing enhancers, Nucleic Acids Res. (2003) 31:3568-3571 [CrossRef] [PubMed].
  7. Courville P., Chaloupka R., Cellier M., Recent progress in structure-function analyses of Nramp proton-dependent metal-ion transporters, Biochem. Cell Biol. (2006) 84:960-978 [PubMed].
  8. Duprey Z., Steurer F., Rooney J., Kirchhoff L., Jackson J., Rowton E., Schantz P., Canine visceral leishmaniasis, United States and Canada, 2000-2003, Emerging Infect. Dis. (2006) 12:440-446 [PubMed].
  9. El-Safi S., Kheir M., Bucheton B., Argiro L., Abel L., Dereure J., et al., Genes and environment in susceptibility to visceral leishmaniasis, C. R. Biol. (2006) 329:863-870 [CrossRef] [PubMed].
  10. Enserink M., Infectious diseases. Has leishmaniasis become endemic in the USA?, Science (2000) 290:1881-1883 [CrossRef] [PubMed].
  11. França-Silva J., da Costa R., Siqueira A., Machado-Coelho G., da Costa C., Mayrink W., et al., Epidemiology of canine visceral leishmaniosis in the endemic area of Montes Claros Municipality, Minas Gerais State, Brazil, Vet. Parasitol. (2003)111:161-173.
  12. Gaskin A., Schantz P., Jackson J., Birkenheuer A., Tomlinson L., Gramiccia M., et al., Visceral leishmaniasis in a New York foxhound kennel, J. Vet. Intern. Med. (2002) 16:34-44 [CrossRef] [PubMed].
  13. Gruenheid S., Pinner E., Desjardins M., Gros P., Natural resistance to infection with intracellular pathogens: the Nramp1 protein is recruited to the membrane of the phagosome, J. Exp. Med. (1997) 185:717-730 [CrossRef] [PubMed].
  14. Kennedy L., Barnes A., Short A., Brown J., Lester S., Seddon J., et al., Canine DLA diversity: 1. New alleles and haplotypes, Tissue Antigens (2007) 69S1:272-288.
  15. Kimchi-Sarfaty C., Oh J., Kim I., Sauna Z., Calcagno A., Ambudkar S., Gottesman M., A "silent" polymorphism in the MDR1 gene changes substrate specificity, Science (2007) 315:525-528 [CrossRef] [PubMed].
  16. McNeil D., Epidemiological research methods, John Wiley and Sons, New York, 1996.
  17. Mohamed H., Ibrahim M., Miller E., White J., Cordell H., Howson J., et al., SLC11A1 (formerly NRAMP1) a nd susceptibility to visceral leishmaniasis in The Sudan, Eur. J. Hum. Genet. (2004) 12:66-74 [CrossRef] [PubMed].
  18. Owens S., Oakley D., Marryott K., Hatchett W., Walton R., Nolan T., et al., Transmission of visceral leishmaniasis through blood transfusions from infected English foxhounds to anemic dogs, J. Am. Vet. Med. Assoc. (2001) 219:1076-1083 [CrossRef] [PubMed].
  19. Quinnell R., Kennedy L., Barnes A., Courtenay O., Dye C., Garcez L., et al., Susceptibility to visceral leishmaniasis i n t he domestic dog is associated with MHC class II polymorphism, Immunogenetics (2003) 55:23-28 [PubMed].
  20. Raymond M., Rousset F., GENEPOP (version 1.2): population genetics software for exact tests and ecumenicism, J. Hered. (1995) 86:248-249.
  21. Rosypal A., Zajac A., Lindsay D., Canine visceral leishmaniasis and its emergence in the United States, Vet. Clin. North Am. Small Anim. Pract. (2003) 33:921-937 [CrossRef] [PubMed].
  22. Roura X., Sánchez A., Ferrer L., Diagnosis of canine leishmaniasis by a polymerase chain reaction technique, Vet. Rec. (1999) 144:262-264 [PubMed].
  23. Sanchez-Robert E., Altet L., Sanchez A., Francino O., Polymorphism of Slc11a1 (Nramp1) gene and canine leishmaniasis in a case-control study, J. Hered. (2005) 96:755-758 [CrossRef] [PubMed].
  24. Schantz P., Steurer F., Duprey Z., Kurpel K., Barr S., Jackson J., et al., Autochthonous visceral leishmaniasis in dogs in North America, J. Am. Vet. Med. Assoc. (2005) 226:1316-1322 [CrossRef] [PubMed].
  25. Searle S., Blackwell J., Evidence for a functional repeat polymorphism in the promoter of the human NRAMP1 gene that correlates with autoimmune versus infectious disease susceptibility, J. Med. Genet. (1999) 36:295-299 [PubMed].
  26. Shaw S., Lerga A., Williams S., Beugnet F., Birtles R., Day M., Kenny M., Review of exotic infectious diseases in small animals e ntering t he United Kingdom from abroad diagnosed by PCR, Vet. Rec. (2003) 152:176-177 [PubMed].
  27. Smith P., Zhang C., Wang J., Chew S., Zhang M., Krainer A., An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers, Hum. Mol. Genet. (2006) 15: 2490-2508.
  28. Solano-Gallego L., Llull J., Ramos G., Riera C., Arboix M., Alberola J., Ferrer L., The Ibizan hound presents a predominantly cellular immune response against natural Leishmania infection, Vet. Parasitol. (2000) 90:37-45 [CrossRef] [PubMed].
  29. Solano-Gallego L., Morell P., Arboix M., Alberola J., Ferrer L., Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology, J. Clin. Microbiol. (2001) 39:560-563 [CrossRef] [PubMed].
  30. Stephens M., Donnelly P., A comparison of bayesian methods for haplotype reconstruction from population genotype data, Am. J. Hum. Genet. (2003) 73:1162-1169 [CrossRef] [PubMed].
  31. Stephens M., Smith N., Donnelly P., A new statistical method for haplotype reconstruction from population data, Am. J. Hum. Genet. (2001) 68:978-989 [CrossRef] [PubMed].
  32. Tazi J., Durand S., Jeanteur P., The spliceosome: a novel multi-faceted target for therapy, Trends Biochem. Sci. (2005) 30:469-478 [CrossRef] [PubMed].
  33. Wingender E., Chen X., Hehl R., Karas H., Liebich I., Matys V. et al., TRANSFAC: an integrated system for gene expression regulation, Nucleic Acids Res. (2000) 28:316-319 [CrossRef] [PubMed].
  34. Xie T., Ding D., Tao X., Dafu D., The relationship between synonymous codon usage and protein structure, FEBS Lett. (1998) 434:93-96 [CrossRef] [PubMed].
  35. Zaahl M., Robson K., Warnich L., Kotze M., Expression of the SLC11A1 (NRAMP1) 5'-(GT)n repeat: opposite effect in the presence of -237C->T, Blood Cells Mol. Dis. (2004) 33:45-50 [CrossRef] [PubMed].